Farther Finance Advisors’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
MNBTD
GI
VCM
MPWT
TWD
Farther Finance Advisors's ANGO Position: Q3 2026 in Review
Farther Finance Advisors reduced its AngioDynamics (ANGO) stake by 51% in Q3 2026, selling an estimated $16.5K and leaving 1,042 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #4321.
Farther Finance Advisors first reported a position in ANGO in Q4 2022 and has held it in 14 quarters since. The position peaked at $28K in Q2 2026. 7 funds tracked by Wall St. Rank hold ANGO as of Q3 2026.
- Farther Finance Advisors held 1,042 shares of AngioDynamics worth $16K as of Q3 2026.
- Farther Finance Advisors sold 1,105 AngioDynamics shares in Q3 2026, an estimated $16.5K.
- AngioDynamics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4321 holding.
- Farther Finance Advisors first reported a position in AngioDynamics in Q4 2022 and has held it in 14 quarters since.
- Farther Finance Advisors's AngioDynamics position peaked at $28K in Q2 2026.
- 7 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2026.
Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.